PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.
Click the orange button to the right to learn more.
Resveratrol and Marfan Syndrome: Can It Slow Aortic Aneurysm Growth? Can resveratrol help slow the growth of aortic aneurysms in Marfan syndrome? Learn what research shows about this natural compound and evidence-based strategies to protect your aorta.
I have recently been diagnosed with Marfan Syndrome. I am also a cancer survivor whose conventional therapies left me with a host of long-term and late-stage side effects. As a result, I would prefer not to undergo any conventional treatments for my heart. According to the research below, resveratrol stabilizes aortic growth in Marfan patients.
My aortic root and my descending aorta both are slightly larger than “normal.” I am relying on many of the non-conventional therapies listed below to also slow any growth.
Marfan syndrome is a genetic disorder that weakens the body’s connective tissues—the fibers that support and anchor organs, blood vessels, and bones. It commonly causes individuals to be unusually tall and thin with long limbs, and it poses serious, life-threatening risks to the heart and aorta. [1, 2]
An enlarged aorta (aortic aneurysm or dilation) is dangerous because the stretched, weakened vessel wall becomes increasingly susceptible to catastrophic tearing or bursting under the constant pressure of blood flow. These sudden events cut off blood supply to vital organs and cause life-threatening internal bleeding. [1, 2, 3]
Resveratrol is a plant polyphenol and antioxidant found in the skin of red grapes, berries, peanuts, and red wine. It is renowned for its potential anti-inflammatory and cardiovascular benefits, though the high dosages used in supplements are still being researched for their efficacy and long-term effects in humans. [1, 2, 3, 4]
Research indicates that resveratrol shows promise in slowing the rate of aortic dilatation in Marfan syndrome (MFS) models, though clinical trial results in humans remain mixed. While initial animal studies demonstrated that the dietary supplement promotes aortic repair and reduces cell death, recent human trials observed a trend toward reduced aortic growth, though it was not statistically significant. [1, 2, 3, 4, 5]
Resveratrol protects the aorta primarily through its potent antioxidant, anti-inflammatory, and structural-preservation properties. By combating cellular stress and regulating key genetic pathways, this natural polyphenol helps prevent arterial stiffness, stabilize existing plaque, and slow the progression of aortic aneurysms and dissections. [1, 2, 3, 4]
Research limitations are the inherent weaknesses or constraints of a study that impact the validity, scope, and generalizability of its findings. They arise from choices in research design, methodology, or practical factors outside the researcher’s control, such as time, funding, and data availability. [1, 2, 3, 4]
Early research suggests that resveratrol may help slow aortic enlargement in Marfan syndrome by reducing inflammation, oxidative stress, and abnormal signaling pathways involved in aortic aneurysm formation. Human evidence remains limited, but the findings are promising.
In the above video Dr. Castro mentions a range of 5.0 – 5.5 centimeters as the size of aortic root dilation for a person to consider surgery. My aortic root, as of my most recent echocardiogram, was 5.1 centimeters.
Further, Dr. Castro confirms that people that are greater than average height can have aortic roots that are greater than average.
I am 6’6″ in height. I will continue to rely on evidence-based non-conventional therapies to manage my aortic root dilation and also get an echo annually to keep an eye on things.
Are you a Marfan Syndrome survivor? Do you have any heart issues? How do you manage your Marfans?
Post below or email me at David.PeopleBeatingCancer@gmail.com
Thank you,
“Background Resveratrol, a dietary supplement that intervenes in cellular metabolism, has been shown to reduce aortic growth rate in a mouse model of Marfan syndrome (MFS), a condition associated in humans with life-threatening aortic complications, often preceded by aortic dilatation. The primary objective of this study was to investigate the effects of resveratrol on aortic growth rate in patients with MFS .
Methods In this investigator-initiated, single-arm open-label multicentre trial, we analysed resveratrol treatment in adults aged 18–50 years with MFS. The primary endpoint was the change in estimated annual aortic growth at five predefined levels in the thoracic aorta after 1 year of resveratrol treatment, evaluated using a linear mixed model. Aortic diameters were measured by cardiac MRI at three time points to analyse the annual aortic expansion rate before and after initiation of treatment. Additionally, annual aortic growth was compared with growth in a previously conducted losartan randomised clinical trial.
Results 898 patients were screened of which 19% (168/898) patients met the inclusion criteria.
36% (61/168) patients signed informed consent and 93% (57/61) aged 37±9 years, of which 28 males (49%) were included in the final analysis of the study. 46% (26/57) had undergone aortic root replacement prior to the study. Aortic root diameters remained stable after 1.2±0.3 years of resveratrol administration. A trend towards a decrease in estimated growth rate (mm/year) was observed in the aortic root (from 0.39±0.06 to −0.13±0.23, p=0.072), ascending aorta (from 0.40±0.05 to −0.01±0.18, p=0.072) and distal descending aorta (from 0.32±0.04 to 0.01±0.14, p=0.072).
Conclusion Resveratrol treatment for 1 year may stabilise the aortic growth rate in adult patients with MFS (resveratrol stabilizes aortic growth in Marfan patients). However, a subsequent randomised clinical trial with a longer follow-up duration and a larger study cohort is needed to establish an actual long-term beneficial effect of this dietary supplement in patients with MFS.